UHS
50
-4
RCL
48
-5
CAH
34
-6
MTCH
34
4
DO
51
-2
COF
23
-5
APA
60
3
FRT
33
-5
MLM
50
-3
PEG
58
-7
K
45
-3
HCP
31
-8
AIV
55
4
BK
27
-5
WM
60
-7
PLD
33
-5
AMT
21
-9
AN
43
-6
ZION
44
8
BIIB
70
14
UHS
50
-4
RCL
48
-5
CAH
34
-6
MTCH
34
4
DO
51
-2
COF
23
-5
APA
60
3
FRT
33
-5
MLM
50
-3
PEG
58
-7
K
45
-3
HCP
31
-8
AIV
55
4
BK
27
-5
WM
60
-7
PLD
33
-5
AMT
21
-9
AN
43
-6
ZION
44
8
BIIB
70
14
Financhill
Back

Arcus Biosciences 10K Form

Sell
36

RCUS
Arcus Biosciences

Last Price:
16.34
Seasonality Move:
17.96%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RCUS News And Ratings

See the #1 stock for the next 7 days that we like better than RCUS

RCUS Financial Statistics

Sales & Book Value

Annual Sales: $112M
Cash Flow: $-70.62M
Price / Cash Flow: 2.7
Annual Sales: $9.01
Price / Book: 1.77

Profitability

EPS (TTM): -3.72000
Net Income (TTM): $-267M
Gross Margin: --
Return on Equity: -35.68%
Return on Assets: -18.16%

Arcus Biosciences Earnings Forecast

Key Arcus Biosciences Financial Ratios

  • The Research & Development expenses have been 257.14% of Revenue.
  • The Interest Expense is -0.75% of Operating Income.
  • The Net Earning history of RCUS is -238.39% of Total Revenues.
  • Per Share Earnings over the last 7 years have been positive in 1 years.

Arcus Biosciences Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NYSE
Industry: Biotechnology
Sector: Healthcare
Current Symbol: RCUS
CUSIP: 03969F
Website: arcusbio.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 5.53
Quick Ratio: 5.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RCUS Technical Analysis vs Fundamental Analysis

Sell
36
Arcus Biosciences (RCUS) is a Sell

Is Arcus Biosciences a Buy or a Sell?

  • Arcus Biosciences stock is rated a Sell
    The current Arcus Biosciences [RCUS] share price is $15.96. The Score for RCUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.